Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study
✍ Scribed by A. L. Lamberg; E. Horvath-Puho; S. Christensen; H. T. Sørensen
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 129 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: Chemoprevention is a potentially attractive strategy for decreasing the burden of colorectal cancer (CRC). Preclinical studies suggest that bisphosphonates (BPs) may have direct antitumour effects against CRC. The objective of this study was to determine the effect of ex
## Summary Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causa
Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi